samedan logo
home > pmps > spring 2015 > industry insight
Pharmaceutical Manufacturing and Packing Sourcer

Industry Insight

We live in an ever-changing, technology-driven world, and the tools that affect our lives most are those associated with the management of information and communication. Consider the impact that digital communication platforms, such as Facebook and Twitter, have made on our social (and professional) interactions. Similarly, organisations are now using social media for sharing information, and are becoming increasingly dependent upon effective data retrieval and management to run their businesses. The pharmaceutical industry is no exception – evident in this edition of PMPS, with articles following the theme of ‘information technology’ and how it is being used to drive efficiencies across many areas of the sector.

Martyn Williams and Andrea Grall of COPA-DATA provide reasons why pharma should be considering energy-saving initiatives, not only to reduce carbon emissions and help protect the environment, but because such approaches inevitably result in cost savings. In particular, they describe how an energy data management system can be pivotal in achieving a substantial reduction in energy consumption.

Data management systems are also being adopted by sectors of the industry that were traditionally reliant on paper-based systems. For instance, Kallik’s Neil Gleghorn discusses the implementation of a labelling and artwork management system, and how it can prove beneficial to both marketing and regulatory teams.

There has been much debate in recent years on the subject of personalised medicine and how this can become a reality. Alan Cox at Indigo Lighthouse outlines an interesting scenario where advances in informatics should soon enable patients to self-monitor physiological data in real-time. Such analytics could be transmitted directly to electronic medical records, which would lead to a far more efficient interface between patient and doctor.

On a slightly different theme, but still related to information technology, ABB’s Mike Wilson proposes the use of robotics in pharmaceutical manufacturing. Robots can be found in many product testing laboratories throughout the pharma industry – despite this, the thought of a pharmaceutical manufacturing facility where all the activities are performed by automated systems is certainly an eyebrow raiser. Yet perhaps this is not such a futuristic idea after all; the use of robots on car assembly lines has been a general practice for many years. Why should the manufacture of pharmaceutical products be any more difficult to automate than car production?

Another focus in this edition relates to the design and construction of facilities. Todd Hallam at Chalcroft brings our attention to the recently revised UK Construction (Design and Management) Regulations, while Teknomek’s Sue Springett talks of a framework for good practice in the installation of labs and cleanrooms.

With plenty more hot topics covered – from clean sealing guidance and tablet tooling, to emerging market growth and its impact on over-the-counter drugs – there is much to be learned from this issue. I hope you enjoy it.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.


Print this page
Send to a friend
Privacy statement
News and Press Releases

Bio-Rad Launches Its CFX Opus Dx Real-Time PCR Detection Systems for In Vitro Diagnostics

HERCULES, Calif.–October 21, 2021–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the CFX™ Opus 96 Dx System and the CFX™ Opus 384 Dx System
More info >>

White Papers

The Role of the CRO in Effective Risk-Based Monitoring


The clinical trial industry is evolving. In an effort to improve participant safety and data integrity, regulators are encouraging trial sponsors to transition from a focused on-site monitoring approach they have traditionally employed toward a risk-based approach that utilizes a combination of centralized and on-site monitoring techniques to ensure patient safety and data quality. The Risk-Based Monitoring (RBM) paradigm has many potential advantages over established monitoring practices including enhanced patient safety and data integrity, more efficient and effective protocol design, reduced costs, and the ability to strategically adjust oversight in keeping with changes in risk level.
More info >>




©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement